con edison dsip Invests for Summer 2020 and New York's Clean Distributed System Implementation Plans |

BPC-157 (Body Protection Compound-157) to syntetyczny peptyd opisany po raz pierwszy na pocztku lat 90

In a physical dependence assay (assessed at 6, 14, 42, and 72 hours after the conditioning treatment) shorter pre-convulsive latencies were noted in diazepam conditioned mice than in non-conditioned healthy mice following an isoniazid treatment forty-two and seventy-two hours after the conditioning treatment

In animal-based models of depressive-like behavior, administration of the peptide was linked to attenuation of behavioral symptoms, indicating possible antidepressant-like activity under experimental conditions (25,26)

Con Edison also has six steam plants throughout New York City with over 3,000 steam machines

BPC-157 is a research-stage compound without the extensive Phase I, II, and III clinical trials that FDA-approved medications undergo